Qing Dong

Title: Qing Dong - Innovator in Therapeutic Proteins

Introduction

Qing Dong is a notable inventor based in Boonton, NJ (US). He has made significant contributions to the field of therapeutic proteins, particularly through his innovative patent.

Latest Patents

Qing Dong holds a patent for "PASylated VEGFR/PDGFR fusion proteins and their use in therapy." This patent describes a protein that comprises a domain of the Platelet-Derived Growth Factor receptor (PDGFR) and a domain of the Vascular Endothelial Growth Factor receptor (VEGFR). In a preferred embodiment, the PDGFR and VEGFR domains are connected by a linker made of proline, alanine, and serine. Additionally, these domains can also be linked by a combination of proline and alanine. The patent also covers compositions that include these proteins and their therapeutic applications.

Career Highlights

Qing Dong is associated with Xl-Protein GmbH, where he continues to advance his research and development in the field of protein therapeutics. His work has the potential to impact various therapeutic areas significantly.

Collaborations

Qing Dong collaborates with Michaela Gebauer, who is also involved in the research and development of innovative therapeutic solutions.

Conclusion

Qing Dong's contributions to the field of therapeutic proteins through his patent highlight his role as an innovator in biotechnology. His work continues to pave the way for advancements in medical therapies.